RxDoctor Payments DataLook up a doctor →

Nicole McKenzie, APRN

Family · Norwich, CTNPI 1699144071

Payments from drug & device makers

$15,731in general payments, 2019–2025

Across 792 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • Bayer$939
  • Rigel Pharmaceuticals, Inc.$898
  • Pfizer$880
  • Novartis$721
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$15,27197%
  • Education$4603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)77$1,472
AstraZeneca(2 entities)54$1,112
Bayer34$939
Rigel Pharmaceuticals, Inc.51$898
Pfizer54$880
Novartis40$721
Incyte Corporation40$687
Sanofi27$513
AbbVie29$488
Bristol Myers Squibb24$486
Amgen17$486
Genentech USA, Inc.28$470
Seagen Inc.23$402
Lilly USA, LLC21$383
Astellas Pharma US Inc19$367
Sobi, Inc14$358
Merck18$338
Takeda Pharmaceuticals U.S.A., Inc.16$336
Eisai Inc.16$310
Mirati Therapeutics, Inc.7$245
Blueprint Medicines Corporation9$238
Jazz Pharmaceuticals Inc.14$217
Ipsen Biopharmaceuticals, Inc8$217
Array Biopharma Inc13$216
Pharmacyclics LLC, An Abbvie Company10$214
Karyopharm Therapeutics Inc.9$210
ADC Therapeutics America, Inc.8$187
AVEO Pharmaceuticals, Inc.6$183
Gilead(2 entities)9$173
Beigene USA, Inc.4$158
Regeneron Healthcare Solutions, Inc.7$156
Geron Corporation6$148
Epizyme, Inc.8$131
Stemline Therapeutics Inc.6$122
EMD Serono, Inc.5$108
Pharmaessentia USA Corporation5$106
Acrotech Biopharma Inc.4$83
Coherus Oncology, Inc.4$81
Sumitomo Pharma America, Inc.3$68
Agios Pharmaceuticals, Inc.3$65
Beone Medicines USA, Inc.3$62
GSK2$56
Morphosys, US Inc.4$54
Daiichi Sankyo Inc.3$54
Servier Pharmaceuticals LLC2$50
E.r. Squibb & Sons, L.L.C.3$46
Organon2$42
AMAG Pharmaceuticals, Inc.3$42
Taiho Oncology, Inc.2$38
Pharmacosmos Therapeutics Inc.2$35
Foundation Medicine, Inc.2$30
Myriad Genetic Laboratories, Inc.2$30
Verastem, Inc.1$24
Myovant Sciences Inc.1$21
CTI Biopharma Corp.1$20
Alnylam Pharmaceuticals Inc.1$20
Progenics Pharmaceuticals, Inc.1$19
Sirtex Medical Inc1$19
Genmab U.S., Inc.1$18
Boehringer Ingelheim1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,731 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Medicare billing

Part B allowed, 2024
$3,430
Medicare patients
25
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Norwich

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →